Skip to main content
Clinical Trials/NCT03404986
NCT03404986
Completed
Not Applicable

Ultrasound Guided Ureteroscopy for the Treatment of Lower Third Ureteric Stones in Adults

Assiut University1 site in 1 country80 target enrollmentApril 1, 2018
ConditionsUreteric Stone

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Ureteric Stone
Sponsor
Assiut University
Enrollment
80
Locations
1
Primary Endpoint
Number of patients treated effectively by the two methods
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The prevalence of urolithiasis is steadily increasing with an estimation of 1 out of 11 people in the United States. The prevalence of calculi in Afro-Asian region including Arab Republic of Egypt ranges from 4% to 20%. Ureteroscopy is one of the first line treatments for definitive management of ureteric stones. Conventional ureteroscopy relies on intraoperative fluoroscopy for visualization and guidance, exposing the patient, surgeon and operating room staff to ionizing radiation. To minimize the hazards of ionizing radiation there has been a trend toward radiation free alternative imaging modalities . Ultrasound provides an excellent alternative for upper urinary tract imaging because it is radiation free, rapid, portable and allows excellent visualization of the renal pelvis and calyces. There is increasing awareness and concern about the clinical use of ionizing radiation and the need to decrease exposure of patients and medical professionals. Ultrasound guided ureteroscopy in pregnant females and children- in whom fluoroscopy is to be minimized or avoided when possible - has been reported.

Registry
clinicaltrials.gov
Start Date
April 1, 2018
End Date
April 1, 2020
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mohamed Loay

Resident

Assiut University

Eligibility Criteria

Inclusion Criteria

  • Patients with single symptomatic lower third ureteric radio-opaque stones indicated for endoscopic treatment.
  • Age group 18 years old or above.
  • Stone size 15 mm or less.

Exclusion Criteria

  • Patients with bilateral ureteric stones
  • Ureteric congenital anomalies e.g. double ureter and ectopic ureter.
  • Previously failed ureteroscopy or previous ureteroneocystostomy.

Outcomes

Primary Outcomes

Number of patients treated effectively by the two methods

Time Frame: 1 hour

Study Sites (1)

Loading locations...

Similar Trials